论文部分内容阅读
多药耐药是白血病治疗中的一个难题,随着P- 糖蛋白(P—glycoprotein,P—gp)等肿瘤耐药蛋白的发现及相关调节剂在临床上的应用为复发及难治性白血病的治疗开辟了一个新的途径。本文就对白血
Multidrug resistance (MDR) is a difficult problem in the treatment of leukemia. With the discovery of tumor-resistant proteins such as P-glycoprotein (P-gp) and the related regulators in clinic, they are relapsed and refractory leukemia The treatment has opened up a new avenue. This article on white blood